Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand

References

• Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–965.
   PubMed Web of Science ®Google Scholar
• Maneekarn N, Khamrin P. Rotavirus associated gastroenteritis in Thailand. VirusDisease. 2014;25(2):201–207.
   PubMedGoogle Scholar
• Muangchana C, Riewpaiboon A, Jiamsiri S, et al., Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Vaccine. 2012;30(18): 2839–2847.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285–296.
   PubMedGoogle Scholar
• Chotivitayatarakorn P, Poovorawan Y. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children. Southeast Asian J Trop Med Public Health. 2010;41(1):114–125.
   PubMed Web of Science ®Google Scholar
• Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis. 2009;48(2):222–228.
   PubMed Web of Science ®Google Scholar
• Tharmaphornpilas P, Jiamsiri S, Boonchaiya S, et al., Evaluating the first introduction of rotavirus vaccine in Thailand: moving from evidence to policy. Vaccine. 2017;35(5): 796–801. .
   PubMed Web of Science ®Google Scholar
• Jiraphongsa C, Bresee JS, Pongsuwanna Y, et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis. 2005;192(Suppl 1):S87–93.
   PubMed Web of Science ®Google Scholar
• Jit M, Bilcke J, Mangen MJ, et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine. 2009;27(44):6121–6128.
   PubMed Web of Science ®Google Scholar
• Tilson L, Jit M, Schmitz S, et al. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine. 2011;29(43):7463–7473.
   PubMed Web of Science ®Google Scholar
• Jiraphongsa C, Laosiritaworn Y, Ngowabunpat A. Diarrhea mortality in children 0–5 years old in Thailand, 2001–2004. Bulletin Dep Med Serv. 2005;30(2):43–51.
   Google Scholar
• Ministry of Public Health. Public health statistics 2017 [ cited 2021 Mar 8]. Available from: http://www.pcko.moph.go.th/Health-Statistics/stratistics60.pdf
   Google Scholar
• Rheingans RD, Constenla D, Antil L, et al. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica. 2007;21(4):205–216.
   PubMed Web of Science ®Google Scholar
• Salinas B, Perez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24(9):807–816.
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–1189.
   PubMed Web of Science ®Google Scholar
• Wilopo SA, Kilgore P, Kosen S, et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine. 2009;27(Suppl 5):F67–74.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Parashar UD, Jiang B. Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: an overview. Infect Genet Evol. 2014;28:561–571.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Introdution of rotavirus vaccines. Geneva, Switzerland: WHO press; 2013 [ cited 2018 Jun 12]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/sentinel/rotavirus_intro_guidance_who_july31_2013.pdf
   Google Scholar
• Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of rotavirus vaccination in vietnam. BMC Public Health. 2009;9(1):29.
   PubMed Web of Science ®Google Scholar
• Loganathan T, Ng CW, Lee WS, et al. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia. Health Policy Plan. 2018;33(2):204–214.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. MI4A: vaccine purchase data 2019 [ cited 2020 10 February]. Available from: https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module1/en/
   Google Scholar
• Riewpaiboon A, Sooksriwong C, Chaiyakunapruk N, et al. Optimizing national immunization program supply chain management in Thailand: an economic analysis. Public Health. 2015;129(7):899–906.
   PubMed Web of Science ®Google Scholar
• Rochanathimoke O, Riewpaiboon A, Tharmaphornpilas P, et al., Economic burden of rotavirus diarrhea in Thailand: report from a pilot study on rotavirus vaccination. Vaccine. 2019;37(4): 587–594. . .
   PubMed Web of Science ®Google Scholar
• Office of The National Economic and Social Development Board. National income of Thailand. [ cited 2021 8 March]. Available from: https://www.nesdc.go.th/nesdb_en/main.php?filename=national_account
   Google Scholar
• Riewpaiboon A. Measurement of costs for health economic evaluation. J Med Assoc Thai. 2014;97(Suppl 5):S17–26.
   PubMedGoogle Scholar
• Bureau of Trade and Economic Indices, Ministry of Commerce. Report for consumer price index of Thailand.[ cited 2021 1 March]. Available from: http://www.price.moc.go.th/price/cpi/index_new_all.asp
   Google Scholar
• Bank of Thailand. Rates of exchange of commercial banks in Bangkok metropolis. [ cited 2021 8 March]. Available from: http://www2.bot.or.th/statistics/ReportPage.aspx?reportID=123&language=eng
   Google Scholar
• Permsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thai. 2014; 97(Suppl 5):S50–58.
   PubMedGoogle Scholar
• Rochanathimoke O, Riewpaiboon A, Postma MJ, et al., Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018;18(2): 215–222.
   PubMed Web of Science ®Google Scholar
• Ruuska T, Vesikari T. Rotavirus disease in finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22(3):259–267.
   PubMed Web of Science ®Google Scholar
• Official statistics registration systems. Population statistics. [ cited 2021 8 March]. Available from: https://stat.bora.dopa.go.th/stat/statnew/statyear/#/TableTemplate/Area/statbirth
   Google Scholar
• The Health Economic Working Group. Meeting of the health economic working group on 22 May 2013. Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand 2013.
   Google Scholar
• Kotirum S, Vutipongsatorn N, Kongpakwattana K, et al. Global economic evaluations of rotavirus vaccines: a systematic review. Vaccine. 2017;35(26):3364–3386.
   PubMed Web of Science ®Google Scholar
• Tu HA, Woerdenbag HJ, Kane S, et al. Economic evaluations of rotavirus immunization for developing countries: a review of the literature. Expert Rev Vaccines. 2011;10(7):1037–1051.
   PubMed Web of Science ®Google Scholar
• Rose J, Hawthorn RL, Watts B, et al. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009;339(sep25 1):b3653.
   PubMed Web of Science ®Google Scholar
• Plosker GL. Rotavirus vaccine RIX4414 (Rotarix): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries. Pharmacoeconomics. 2011;29(5):439–454.
   PubMed Web of Science ®Google Scholar
• Postma MJ, Jit M, Rozenbaum MH, et al. Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world. BMC Med. 2011;9(1):84.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–298.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–614.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):615–623.
   PubMed Web of Science ®Google Scholar
• Leshem E, Lopman B, Glass R, et al. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(9):847–856.
   PubMed Web of Science ®Google Scholar